NextGenMicrofluidics combines the competencies of 21 companies and research organizations along the entire value chain in the development of microfluidic lab-on-a-foil systems and offers services for the development and production of these systems for companies – from start-ups to large-scale industry. This H2020 project tested the collaboration across 5 demo cases.
In this demo case, partners collaborated on the development of a molecular diagnostics assayfor the multiplexed detection of SARS-CoV-2 and Influenza as well as the employment of aptamers for the detection of contaminants in food.
The production of the individual components of biochemical and molecular diagnostics assays and microfluidic systems like sensor chip and foils, surface functionalization and spotting were scaled up. These developments led to a simulation-based assay design and microfluidic and sensor channel library, both easily customizable to the needs of different assays and readout platforms, fluidic structuring of low-autofluorescence materials such as COP and novel materials such as biodegradable thermoplastics and self-powered fluidic actuation with disposable micropumps and microvalves.
On 22 January 2025 from 14:00-15:00 CET, join speakers George Tsekenis, Biomedical Research Foundation of the Academy of Athens (BRFAA) and Jörg Nestler of BiFlow Systems to learn more about this technology and its potential applications
Beyond the project, the Microfluidics Innovation Hub (MIH) offers customers a single entry point to a wide range of existing cutting edge microfluidic technologies from Europe’s top research centres and companies, covering the entire value chain to accelerate the demonstration of exciting new scientific breakthroughs towards a working prototype, and beyond into mass manufacturing.
